Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation
Conditions: Acute Lymphoblastic Leukemia (ALL); Acute Myeloid Leukemia (AML); Myeloid Sarcoma; Chronic Myeloid Leukemia (CML); Juvenile Myelomonocytic Leukemia (JMML); Myelodysplastic Syndrome (MDS); Non-Hodgkin Lymphoma (NHL)
Interventions: Drug: Anti-thymocyte globulin (rabbit); Drug: Blinatumomab; Drug: Cyclophosphamide; Drug: Fludarabine; Drug: G-CSF; Drug: Melphalan; Drug: Mesna; Drug: Rituximab; Drug: Tacrolimus; Drug: Thiotepa; Biological: HPC,A Infusion
Sponsor: St. Jude Children's Research Hospital
Recruiting - verified December 2016
Interventions: Drug: Anti-thymocyte globulin (rabbit); Drug: Blinatumomab; Drug: Cyclophosphamide; Drug: Fludarabine; Drug: G-CSF; Drug: Melphalan; Drug: Mesna; Drug: Rituximab; Drug: Tacrolimus; Drug: Thiotepa; Biological: HPC,A Infusion
Sponsor: St. Jude Children's Research Hospital
Recruiting - verified December 2016
News Type: